Reuters logo
BRIEF-Mallinckrodt enrolls first patient in Phase 2B trial of H.P. acthar gel
June 14, 2017 / 8:47 PM / 5 months ago

BRIEF-Mallinckrodt enrolls first patient in Phase 2B trial of H.P. acthar gel

June 14 (Reuters) - Mallinckrodt Plc

* Mallinckrodt enrolls first patient in Phase 2B trial of H.P. Acthar® gel (repository corticotropin injection) for amyotrophic lateral sclerosis (ALS) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below